SCHEMBL21628795

SCHEMBL21628795

CC(C)c1ccc(Oc2ccc(C(N)=O)cc2F)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 6/20 0.55
OPRK1 P41145 6/20 0.47
OPRM1 P35372 5/20 0.47
OPRD1 P41143 5/20 0.47
ICAM1 P05362 1/20 0.46
SELE P16581 1/20 0.46
FPR2 P25090 2/20 0.46
SCN9A Q15858 2/20 0.46
SLC6A4 P31645 2/20 0.45
SLC6A2 P23975 1/20 0.45
PARP15 Q460N3 2/20 0.45
PARP14 Q460N5 2/20 0.45
ALDH1A1 P00352 1/20 0.45
KMT2A Q03164 1/20 0.45
PARP16 Q8N5Y8 1/20 0.45
PARP11 Q9NR21 1/20 0.45
PARP4 Q9UKK3 1/20 0.45
TNKS O95271 1/20 0.43
TNKS2 Q9H2K2 1/20 0.43
PARP2 Q9UGN5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628711 0.87 LMNA (0.56) PARP10PTGER4PTGER2
SCHEMBL21628595 0.85 PARP10 (0.51) PARP10OPRK1OPRM1OPRD1SLC6A4
SCHEMBL21628720 0.85 USP2 (0.47) PARP10ALDH1A1KMT2APTGER4PTGER2
SCHEMBL26214383 0.84 PARP10 (0.63) PARP10OPRK1OPRM1OPRD1SLC6A4
SCHEMBL21628730 0.84 PARP10 (0.59) PARP10OPRK1OPRM1OPRD1SLC6A4
SCHEMBL3024115 0.84 PARP10 (0.67) PARP10OPRK1OPRM1OPRD1SLC6A4
SCHEMBL21628675 0.84 PARP10 (0.52) PARP10OPRK1OPRM1OPRD1SCN9A
SCHEMBL21628789 0.84 HDAC6 (0.49) OPRK1OPRM1PTGER4PTGER2
SCHEMBL21628430 0.84 SMN1; SMN2 (0.50) PARP10FPR2SCN9ASLC6A4SLC6A2
SCHEMBL21628622 0.84 HPGD (0.50) PARP10SLC6A4SLC6A2ALDH1A1PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PARP10 1944/4885OPRK1 2780/4885OPRM1 3978/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PARP10 1944/4885OPRK1 2780/4885OPRM1 3978/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK PARP10 1897/4885OPRK1 3124/4885OPRM1 4075/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PARP10 1944/4885OPRK1 2780/4885OPRM1 3978/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR PARP10 3512/4885OPRK1 684/4885OPRM1 817/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PARP10 1944/4885OPRK1 2780/4885OPRM1 3978/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK PARP10 1944/4885OPRK1 2780/4885OPRM1 3978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.